Latest Insider Transactions at Immunomedics Inc (IMMU)
This section provides a real-time view of insider transactions for Immunomedics Inc (IMMU). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of IMMUNOMEDICS INC to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of IMMUNOMEDICS INC's insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Oct 23
2020
|
Barbara Gayle Duncan Director |
SELL
Sale (or disposition) back to the issuer
|
Direct |
49,244
-100.0%
|
-
|
|
Oct 23
2020
|
Charles M Baum Director |
SELL
Sale (or disposition) back to the issuer
|
Direct |
9,667
-100.0%
|
-
|
|
Oct 23
2020
|
Bryan Ball Chief Quality Officer |
SELL
Sale (or disposition) back to the issuer
|
Direct |
10,000
-100.0%
|
-
|
|
Oct 23
2020
|
Khalid Islam Director |
SELL
Sale (or disposition) back to the issuer
|
Direct |
13,516
-100.0%
|
-
|
|
Oct 23
2020
|
Lorettta M Itri Chief Medical Officer |
SELL
Sale (or disposition) back to the issuer
|
Direct |
15,000
-100.0%
|
-
|
|
Oct 23
2020
|
Peter Barton Hutt Director |
SELL
Sale (or disposition) back to the issuer
|
Direct |
13,516
-100.0%
|
-
|
|
Oct 23
2020
|
Scott A Canute Director |
SELL
Sale (or disposition) back to the issuer
|
Direct |
13,516
-100.0%
|
-
|
|
Oct 23
2020
|
Usama Malik Chief Fin. & Business Officer |
SELL
Sale (or disposition) back to the issuer
|
Direct |
18,856
-100.0%
|
-
|
|
Oct 23
2020
|
Behzad Aghazadeh Director |
SELL
Sale (or disposition) back to the issuer
|
Indirect |
26,250,000
-100.0%
|
-
|
|
Oct 23
2020
|
Behzad Aghazadeh Director |
SELL
Sale (or disposition) back to the issuer
|
Direct |
13,516
-100.0%
|
-
|
|
Jun 18
2020
|
Behzad Aghazadeh Director |
BUY
Grant, award, or other acquisition
|
Direct |
3,718
+17.75%
|
-
|
|
May 01
2020
|
Avoro Capital Advisors LLC Director |
BUY
Open market or private purchase
|
Indirect |
1,750,000
+6.25%
|
$49,000,000
$28.5 P/Share
|
|
Mar 20
2020
|
Behzad Aghazadeh Director |
BUY
Grant, award, or other acquisition
|
Direct |
100,000
+50.0%
|
-
|
|
Dec 05
2019
|
Avoro Capital Advisors LLC Director |
BUY
Open market or private purchase
|
Indirect |
2,000,000
+7.55%
|
$34,000,000
$17.5 P/Share
|
|
Oct 03
2019
|
Avoro Capital Advisors LLC Director |
BUY
Open market or private purchase
|
Indirect |
500,000
+2.17%
|
$7,000,000
$14.1 P/Share
|
|
Oct 02
2019
|
Avoro Capital Advisors LLC Director |
BUY
Open market or private purchase
|
Indirect |
1,000,000
+4.35%
|
$13,000,000
$13.23 P/Share
|
|
Jun 28
2019
|
Avoro Capital Advisors LLC Director |
BUY
Open market or private purchase
|
Indirect |
250,000
+1.18%
|
$3,250,000
$13.84 P/Share
|
|
Jun 27
2019
|
Avoro Capital Advisors LLC Director |
BUY
Open market or private purchase
|
Indirect |
350,000
+1.66%
|
$4,550,000
$13.68 P/Share
|
|
Jun 26
2019
|
Avoro Capital Advisors LLC Director |
BUY
Open market or private purchase
|
Indirect |
400,000
+1.92%
|
$5,200,000
$13.25 P/Share
|
|
Jun 07
2019
|
Behzad Aghazadeh Director |
BUY
Grant, award, or other acquisition
|
Direct |
9,667
+41.7%
|
-
|
|
Jun 05
2019
|
Avoro Capital Advisors LLC Director |
BUY
Open market or private purchase
|
Indirect |
250,000
+1.23%
|
$3,000,000
$12.47 P/Share
|
|
Jun 04
2019
|
Avoro Capital Advisors LLC Director |
BUY
Open market or private purchase
|
Indirect |
500,000
+2.47%
|
$6,000,000
$12.1 P/Share
|
|
Jun 03
2019
|
Avoro Capital Advisors LLC Director |
BUY
Open market or private purchase
|
Indirect |
785,539
+3.92%
|
$9,426,468
$12.19 P/Share
|
|
May 15
2019
|
Avoro Capital Advisors LLC Director |
BUY
Open market or private purchase
|
Indirect |
125,000
+0.67%
|
$1,750,000
$14.95 P/Share
|
|
May 14
2019
|
Avoro Capital Advisors LLC Director |
BUY
Open market or private purchase
|
Indirect |
125,000
+0.68%
|
$1,875,000
$15.4 P/Share
|
|
May 13
2019
|
Avoro Capital Advisors LLC Director |
BUY
Open market or private purchase
|
Indirect |
500,000
+2.67%
|
$7,500,000
$15.07 P/Share
|
|
Jun 15
2018
|
Avoro Capital Advisors LLC Director |
BUY
Open market or private purchase
|
Indirect |
775,000
+2.15%
|
$17,825,000
$23.7 P/Share
|
|
Apr 02
2018
|
Behzad Aghazadeh Director |
BUY
Grant, award, or other acquisition
|
Direct |
3,849
+50.0%
|
-
|
|
Feb 16
2018
|
Avoro Capital Advisors LLC Director |
BUY
Exercise of in-the-money or at-the-money derivatives securities
|
Indirect |
875,000
+4.91%
|
$6,125,000
$7.0 P/Share
|
|
Nov 15
2017
|
Avoro Capital Advisors LLC Director |
BUY
Open market or private purchase
|
Indirect |
175,000
+1.08%
|
$1,750,000
$10.97 P/Share
|
|
Nov 14
2017
|
Avoro Capital Advisors LLC Director |
BUY
Open market or private purchase
|
Indirect |
1,150,000
+6.75%
|
$11,500,000
$10.39 P/Share
|
|
Aug 24
2017
|
Behzad Aghazadeh Director |
BUY
Conversion of derivative security
|
Indirect |
4,251,386
+22.39%
|
-
|